Elevance Health, Inc.
ELV
$417.75
-$4.29-1.02%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 36.77B | 37.36B | 35.92B | 36.16B | 35.67B |
| Total Other Revenue | 8.67B | 7.79B | 7.72B | 6.42B | 6.98B |
| Total Revenue | 45.44B | 45.15B | 43.65B | 42.58B | 42.65B |
| Cost of Revenue | 33.50B | 32.95B | 30.57B | 30.55B | 31.33B |
| Gross Profit | 11.94B | 12.20B | 13.07B | 12.03B | 11.31B |
| SG&A Expenses | 10.78B | 10.09B | 9.89B | 8.71B | 8.69B |
| Depreciation & Amortization | 180.00M | 122.00M | 162.00M | 116.00M | 217.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.46B | 43.17B | 40.62B | 39.37B | 40.24B |
| Operating Income | 987.00M | 1.98B | 3.03B | 3.20B | 2.40B |
| Income Before Tax | 606.00M | 1.37B | 2.99B | 2.94B | 1.00B |
| Income Tax Expenses | 193.00M | 365.00M | 685.00M | 690.00M | 170.00M |
| Earnings from Continuing Operations | 413.00M | 1.01B | 2.30B | 2.25B | 831.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.00M | 8.00M | -1.00M | -3.00M | 25.00M |
| Net Income | 418.00M | 1.02B | 2.30B | 2.25B | 856.00M |
| EBIT | 987.00M | 1.98B | 3.03B | 3.20B | 2.40B |
| EBITDA | 1.39B | 2.31B | 3.36B | 3.54B | 2.83B |
| EPS Basic | 1.81 | 4.38 | 9.91 | 9.65 | 3.63 |
| Normalized Basic EPS | 1.77 | 4.56 | 7.39 | 7.88 | 5.79 |
| EPS Diluted | 1.81 | 4.36 | 9.85 | 9.59 | 3.63 |
| Normalized Diluted EPS | 1.77 | 4.54 | 7.35 | 7.83 | 5.79 |
| Average Basic Shares Outstanding | 231.10M | 231.90M | 232.09M | 232.70M | 235.80M |
| Average Diluted Shares Outstanding | 231.10M | 233.10M | 233.40M | 234.20M | 235.80M |
| Dividend Per Share | 1.63 | 1.63 | 1.63 | 1.63 | 1.48 |
| Payout Ratio | 89.23% | 37.20% | 16.43% | 16.87% | 40.42% |
